Terms: = Gastric cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4
576 results:
1. [PCID2 is highly expressed in gastric cancer and affects the prognosis by regulating cancer cell cycle and proliferation].
Zhang N; Zhang Z; Zhang Y; Song X; Zhang X; Li J; Zuo L; Hu J
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Feb; 44(2):324-332. PubMed ID: 38501418
[TBL] [Abstract] [Full Text] [Related]
2. The mechanisms behind the dual role of long non-coding RNA (lncRNA) metastasis suppressor-1 in human tumors: Shedding light on the molecular mechanisms.
Abdullaev B; Alsaab HO; Hjazi A; Alkhafaji AT; Alawadi AH; Hamzah HF
Pathol Res Pract; 2024 Apr; 256():155189. PubMed ID: 38452581
[TBL] [Abstract] [Full Text] [Related]
3. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
[TBL] [Abstract] [Full Text] [Related]
4. cdkn2a-p16 Deletion and Activated KRAS
Sun J; Sepulveda JL; Komissarova EV; Hills C; Seckar TD; LeFevre NM; Simonyan H; Young C; Su G; Del Portillo A; Wang TC; Sepulveda AR
Cell Mol Gastroenterol Hepatol; 2024; 17(5):769-784. PubMed ID: 38296052
[TBL] [Abstract] [Full Text] [Related]
5. Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice.
Papadopoulou E; Rigas G; Fountzilas E; Boutis A; Giassas S; Mitsimponas N; Daliani D; Ziogas DC; Liontos M; Ramfidis V; Christophilakis C; Matthaios D; Floros T; Florou-Chatzigiannidou C; Agiannitopoulos K; Meintani A; Tsantikidi A; Katseli A; Potska K; Tsaousis G; Metaxa-Mariatou V; Nasioulas G
JCO Precis Oncol; 2024 Jan; 8():e2300332. PubMed ID: 38271656
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of rs10811661 polymorphism in cdkn2a / B in colon and gastric cancer.
Beihaghi M; Sahebi R; Beihaghi MR; Nessiani RK; Yarasmi MR; Gholamalizadeh S; Shahabnavaie F; Shojaei M
BMC Cancer; 2023 Oct; 23(1):985. PubMed ID: 37845622
[TBL] [Abstract] [Full Text] [Related]
7. Differences in mutational signature of diffuse large B-cell lymphomas according to the primary organ.
Koh HH; Yoon SE; Kim SJ; Kim WS; Cho J
Cancer Med; 2023 Oct; 12(19):19732-19743. PubMed ID: 37706649
[TBL] [Abstract] [Full Text] [Related]
8. A cuproptosis-related gene signature and associated regulatory axis in stomach adenocarcinoma based on bioinformatics analysis.
Ding D; Wang D; Qin Y
Medicine (Baltimore); 2023 Jul; 102(30):e34230. PubMed ID: 37505170
[TBL] [Abstract] [Full Text] [Related]
9. Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era.
Dermawan JK; Kelly C; Gao Z; Smith S; Jadeja B; Singer S; Tap WD; Chi P; Antonescu CR
Clin Cancer Res; 2023 Oct; 29(19):3974-3985. PubMed ID: 37477937
[TBL] [Abstract] [Full Text] [Related]
10. A quick and reliable image-based AI algorithm for evaluating cellular senescence of gastric organoids.
Yang R; Du Y; Kwan W; Yan R; Shi Q; Zang L; Zhu Z; Zhang J; Li C; Yu Y
Cancer Biol Med; 2023 Jun; 20(7):519-36. PubMed ID: 37417294
[TBL] [Abstract] [Full Text] [Related]
11. The SMAD2/miR-4256/HDAC5/p16
Wang M; Zhao H; Chen W; Bie C; Yang J; Cai W; Wu C; Chen Y; Feng S; Shi Y; Li Y; Tang H; Zhong L; Guo L; Chen S; Long L; Tang S
Oncol Res; 2023; 31(4):515-541. PubMed ID: 37415735
[TBL] [Abstract] [Full Text] [Related]
12. Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric cancer.
Maron SB; Chatila W; Walch H; Chou JF; Ceglia N; Ptashkin R; Do RKG; Paroder V; Pandit-Taskar N; Lewis JS; Biachi De Castria T; Sabwa S; Socolow F; Feder L; Thomas J; Schulze I; Kim K; Elzein A; Bojilova V; Zatzman M; Bhanot U; Nagy RJ; Lee J; Simmons M; Segal M; Ku GY; Ilson DH; Capanu M; Hechtman JF; Merghoub T; Shah S; Schultz N; Solit DB; Janjigian YY
Clin Cancer Res; 2023 Sep; 29(18):3633-3640. PubMed ID: 37406106
[TBL] [Abstract] [Full Text] [Related]
13. Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring
Ohshima K; Nagashima T; Fujiya K; Hatakeyama K; Watanabe Y; Morimoto K; Kamada F; Shimoda Y; Ohnami S; Naruoka A; Serizawa M; Ohnami S; Kenmotsu H; Shiomi A; Tsubosa Y; Bando E; Sugiura T; Sugino T; Terashima M; Uesaka K; Urakami K; Akiyama Y; Yamaguchi K
Cancer Res Commun; 2023 Apr; 3(4):684-696. PubMed ID: 37377752
[TBL] [Abstract] [Full Text] [Related]
14. Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells.
Simbolo M; Silvestris N; Malleo G; Mafficini A; Maggino L; Cocomazzi A; Veghini L; Mombello A; Pezzini F; Sereni E; Martelli FM; Gkountakos A; Ciaparrone C; Piredda ML; Ingravallo G; Paolino G; Nappo F; Rapposelli IG; Frassinetti L; Saragoni L; Lonardi S; Pea A; Paiella S; Fassan M; Brunetti O; Cingarlini S; Salvia R; Milella M; Corbo V; Lawlor RT; Scarpa A; Luchini C
Mod Pathol; 2023 Sep; 36(9):100251. PubMed ID: 37355152
[TBL] [Abstract] [Full Text] [Related]
15. Tumoral Intraductal Neoplasms of the Bile Ducts Comprise Morphologically and Genetically Distinct Entities.
Wang T; Askan G; Ozcan K; Rana S; Zehir A; Bhanot UK; Yantiss RK; Rao DS; Wahl SJ; Bagci P; Balci S; Balachandran V; Jarnagin WR; Adsay NV; Klimstra DS; Basturk O
Arch Pathol Lab Med; 2023 Dec; 147(12):1390-1401. PubMed ID: 36821179
[TBL] [Abstract] [Full Text] [Related]
16. Cervical gastric-type Adenosquamous Carcinoma: Case Report of a Rare Neoplasm Associated With a BRCA1 Pathogenic Variant.
Rajendran S; McGivern U; Gonzalez D; McCluggage WG
Int J Gynecol Pathol; 2023 Sep; 42(5):529-534. PubMed ID: 36811841
[TBL] [Abstract] [Full Text] [Related]
17. ASAP1 activates the IQGAP1/CDC42 pathway to promote tumor progression and chemotherapy resistance in gastric cancer.
Xie W; Han Z; Zuo Z; Xin D; Chen H; Huang J; Zhu S; Lou H; Yu Z; Chen C; Chen S; Hu Y; Huang J; Zhang F; Ni Z; Shen X; Xue X; Lin K
Cell Death Dis; 2023 Feb; 14(2):124. PubMed ID: 36792578
[TBL] [Abstract] [Full Text] [Related]
18. Target tumor therapy in human gastric cancer cells through the combination of docetaxel-loaded cationic lipid microbubbles and ultrasound-triggered microbubble destruction.
Lai B; Ouyang X; Mao S; Cao J; Li H; Li S; Wang J
Funct Integr Genomics; 2023 Feb; 23(1):59. PubMed ID: 36757623
[TBL] [Abstract] [Full Text] [Related]
19. The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma.
Feng M; Xu H; Zhou W; Pan Y
J Exp Clin Cancer Res; 2023 Feb; 42(1):44. PubMed ID: 36755269
[TBL] [Abstract] [Full Text] [Related]
20. On the origin of gastric tumours: analysis of a case with intramucosal gastric carcinoma and oxyntic gland adenoma.
Kumagai K; Shimizu T; Nikaido M; Hirano T; Kakiuchi N; Takeuchi Y; Minamiguchi S; Sakurai T; Teramura M; Utsumi T; Hiramatsu Y; Nakanishi Y; Takai A; Miyamoto S; Ogawa S; Seno H
J Pathol; 2023 Apr; 259(4):362-368. PubMed ID: 36625379
[TBL] [Abstract] [Full Text] [Related]
[Next]
